Navigation Links
MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --
Date:12/26/2008

First and Only Treatment Approved by the Fda For Hypotrichosis of Eyelashes

The U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE(TM) is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Available only through a doctor, LATISSE(TM) is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE(TM) users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE(TM) is required. If use of LATISSE(TM) is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

LATISSE(TM) will be available in the United States by prescription only and is subject to all U.S. guidelines applicable to dispensing a prescription medical product. Based on today's FDA approval, Allergan expects to launch the product nationwide in the first quarter of 2009. Doctors and consumers are encouraged to visit www.latisse.com for further product and prescribing information.

IMPORTANT LATISSE(TM) SAFETY INFORMATION

LATISSE(TM) solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN(R) or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE(TM) under the close superv
'/>"/>

SOURCE Allergan, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MultiVu Video Feed: New Rapid Test to Diagnose Flu May Help With Upcoming Flu Season
2. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
3. MultiVu Video Feed: Easypod(R), Award-Winning Electronic Device
4. MultiVu Video Feed: Hard Rocks 2007 Ambassadors of Rock Tour Is "On the Road Again" With Music Legend Willie Nelson
5. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
6. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
7. New Online Video Features Brazilian Researcher Elbio Rech
8. Video: 8-Minute Film Documentary Explores Why Humans Age
9. PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS
10. Video: Insulet Unveils Video Contest for OmniPod Users
11. [video] Wall St. Networks 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., The concept of confinement is one of the centr...e is that of quarks which bind together to form pr...holtz-Zentrum Berlin together with an internationa...experimental realization and a proof of confinemen.... , The concept of confinement states that in ce...
(Date:11/27/2009)...ye test alternative is helping bring complete aut...oser for pharma-companies. It is a non-destructive... Sepha for use with blister packs and it has alre...rma-companies such as Sanofi-Avenis and Zydus-Cadi...improvements on the packaging line. Blisterscan ...
(Date:11/25/2009)...at Economic Club of Canada , ...mbassador to Speak at Economic Club of Canada., , ...ernational Investment, and Chairman and CEO of the...avid Appia go to www.investinfrance.org . , , ,W...ress to discuss recent pro-business initiatives ad...
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Brazil Bioethanol Market Analysis and Forecas...65503/Brazil-Bioethanol-Market-Analysis-and-Foreca...nalysis and Forecasts to 2013 ,, Summary ,...sts of the global bioethanol market and the Brazil...
Breaking Biology Technology:Spinons -- confined like quarks 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
... DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- Cade...pharmaceutical company focused on in-licensing, de...andidates principally for use in the hospital sett...and CEO Theodore Schroeder will present the compan...09 at 2:00pm Pacific Time (5:00pm Eastern Time) du...
... SEATTLE, Feb. 10 A $50,000 investment fund will ...he ZINO Society and Washington,Biotechnology and B...iences,Investment Forum, to be held February 24, 2...le. , Accredited investors, entrepreneurs, and...ife: Life Sciences Investment Forum. There will ...
... , , National sports nutrition retailer launches...c strain; research shows probiotics help with prot...., Feb. 10 National retailer Max Muscle Sports Nu...the first probiotics-enhanced protein bar introduc... Muscle and Ganeden Biotech, manufacturer of the p...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2ZINO Society Spurring Investments, 12 Life Sciences Companies to Vie for $50,000 ZINO Life Fund 2Max Muscle Introduces First-Ever Probiotics Protein Bar 2Max Muscle Introduces First-Ever Probiotics Protein Bar 3
(Date:11/25/2009)...ember 11, firefighters, police officers and ambula...e World Trade Center complex. They battled to save...for survivors, tackled fires and evacuated as many...n estimated 17,000 people. And making their jobs e... frightened workers and their relatives jammed mob...
(Date:11/25/2009)...e course of a lifetime, the heart pumps some 250 m...der to do this, the muscle fibers of the heart hav...ed by Dr. Wolfgang Rottbauer, vice chair of the De...Hospital (Chairman: Prof. Dr. H. A. Katus), has di...bility of the smallest muscular unit, the sarcomer...
(Date:11/24/2009)...usands of years it has been prescribed by traditio... from headaches and stomach pain to fever and flu....le University have been able to scientifically pro...a otherwise known as Brazilian mint. , Testing ... led by researcher Graciela Rocha was able to show...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2Health Education Solutions 26apos 3B Advanced Cardiac Life Support Courses Gain Approval from American Academy of Physician Assistants 59779 1Health Education Solutions 26apos 3B Advanced Cardiac Life Support Courses Gain Approval from American Academy of Physician Assistants 59779 2The Regence Foundation Announces Debut of Sojourns Award for Innovation and Leadership in Palliative Care 59777 1The Regence Foundation Announces Debut of Sojourns Award for Innovation and Leadership in Palliative Care 59777 2Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 1Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 2Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 3Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 4
...ncer is the second leading cause of death among Am...e in six males will develop the disease during his...s have been developed to help combat this threaten... treatments is robotic-assisted laparoscopic prost... of Pennsylvania Health System is currently one of...
...mbryos for genetic diseases during in vitro fertil...hy child, but a genetic glitch could potentially c...em, University of Florida researchers say. , Citi...genetic diagnosis, the method many practitioners u...esearchers set out to study the procedure. Their w...
...ells that develop in the olfactory system of adult... from that of older neurons. The new olfactory ne...referentially learning to respond to new odors. T...generated neurons could be induced to adapt to and...s allowing them to replace neurons lost to injury ...
Other Biology News:Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 2Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 3Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Neurons generated in the adult brain learn to respond to novel stimuli 2
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
ImageQuant 100 UV from GE Healthcare, formerly Amersham Biosciences
IMAGEQUANT 300 IQTL from GE Healthcare, formerly Amersham Biosciences
Rat PTX2 / SAP, Unconjugated from R&D Systems
Biology Products: